Podcasts about OTC

We’ve all had a nasty headache and run to grab some OTC pain relief, only to get thwarted by the childproof wrapping. But 7 still unsolved murders explain why our meds are wrapped so tight feel free to DM me if you have a story you’d like me to cover . . on Facebook it’s Patty Steele and on Instagram real Patty SteeleSee omnystudio.com/listener for privacy information.

Join Dr. Jay and Brad as they interview this week's guest, Dr. Amy Baxter.Dr. Baxter directs innovation, invention, operations and strategy for Pain Care Labs. After graduating from Yale University and Emory Medical School, as a double boarded pediatric emergency physician Dr. Baxter founded PEMA Emergency Research while also founding Pain Care Labs (initially called MMJ Labs).Her accomplishments include multiple textbook chapters, first author papers, and national and international invited lectures; innovation impact comes from multiple NIH SBIR Fast-Tracks, patents, and successfully pursuing 510(k) FDA clearances.Her academic service includes numerous NIH Scientific Review Groups for multiple institutes, and the COVID-19 ACEP Field Guide Task Force.Her recognition includes Forbes Ten Healthcare Disruptors, Inc. Top Women in Tech to Watch, Top 10 Innovative and Disruptive Women in Healthcare, a Wall Street Journal “Idea Person,” and the Most Innovative CEO from Georgia Bio.Her national and international speaking highlights include HHS testimony, Exponential Medicine “Future of Pain Management”, TEDx, State Department VentureWell keynote, and TEDMED.Dr. Amy Baxter is also known as Robert A. Heinlein's adopted granddaughter and for turning down Mr. Wonderful on Shark Tank.To connect with Dr. Amy Baxter, email her at info@paincarelabs.com or visit her LinkedIn page. More information on Dr. Baxter's products below:Buzzy and VibraCool company: paincarelabs.comDuoTherm company: harmonicscientific.com/Free download from Pain Care Labs - workbook on comprehensive pain management including OTC, supplements, physical interventions, brain-body activities: https://paincarelabs.com/hubfs/What%20Works%20for%20Pain%20Booklet%2002.pdf?hsLang=en

“And what the world really needs is this flexibility on energy and the agility to ensure access and affordability. And that's where steering the offshore energy business is really critical.” Offshore energy is evolving quickly as global demand grows and new technologies emerge across oil and gas, offshore wind, and other energy systems. Alex Martinez and Joe Reilly discuss why the Offshore Technology Conference remains one of the most important places for engineers, geoscientists, and industry leaders to collaborate and share ideas. OTC 2026 in Houston (4-7 May 2026) brings the full offshore energy community together to explore solutions that will shape a reliable and sustainable energy future. KEY TAKEAWAYS > Rising global energy demand is driving offshore innovation. Growing energy needs are pushing companies to improve efficiency and develop new technologies across both traditional offshore oil and gas and emerging energy solutions. > OTC creates a unique space for cross-disciplinary collaboration. Experts from many technical fields come together to share ideas and solve complex offshore energy challenges. > Geoscientists play an important role in the future of offshore energy. Understanding the subsurface remains critical for oil and gas, offshore wind, and carbon storage projects. LINKS * Learn more OTC '26 - https://2026.otcnet.org/ * Register for the event (4-7 May 2026) - https://2026.otcnet.org/registration ABOUT SEISMIC SOUNDOFF Seismic Soundoff showcases conversations addressing the challenges of energy, water, and climate. Produced by the Society of Exploration Geophysicists (SEG) and hosted by Andrew Geary of 51 features, these episodes celebrate and inspire the geophysicists of today and tomorrow. Three new episodes monthly. See the full archive at https://seg.org/resources/podcast/.

Bisher Khudeira is the COO of Stormrake, a Melbourne-based digital asset brokerage offering best execution trading, institutional custody, and asset management across Bitcoin, digital assets, and tokenized real-world assets. Bisher joins Andy to explain why the brokerage model beats the exchange model for serious investors, what it takes to build a crypto business in one of the most hostile banking environments in the developed world, and why Stormrake is about to plant its flag in Dallas. Why you should listen Bisher has spent a decade in financial services, starting in foreign exchange brokering in 2015 and buying his first Bitcoin in a McDonald's car park in 2016 via peer-to-peer. He joined Stormrake in 2022, bought into the business, and has helped scale it from fewer than a hundred clients — mostly friends and family — to over 10,000 across Australia, with a US launch now weeks away. He walks through the core brokerage proposition: Stormrake faces around 20 exchanges and OTC desks simultaneously, aggregates client orders to access deeper liquidity and sharper pricing, and charges a flat commission with no spread markup. The result is what Bisher calls the Satoshi maximiser — clients walk away with more Bitcoin per transaction than they would going it alone on a single exchange. The conversation covers Stormrake's two wholesale funds: the Cumulus class, which targets picks-and-shovels digital assets like Ethereum, Solana, Hyperliquid, and Chainlink alongside select private equity plays; and the Stratus class, a Bitcoin and gold fund designed to smooth out Bitcoin's volatility while improving on gold's growth profile. Bisher also details the custody offering — fully institutional grade with insurance, separation of funds, and cold storage as default — while stressing that Stormrake fully supports self-custody for clients who want it. The US expansion into Dallas, two years in the making and launching end of April 2026, is built as a direct lift-and-shift of the Australian model into a jurisdiction where digital asset brokers are treated as normal participants in the economy rather than pariahs. Bisher doesn't hold back on the state of Australian banking, describing three personal debankings and ongoing hostility from the big four toward crypto businesses and their clients. He argues Australia is a decade behind the US on digital asset regulation, with an AFSL licensing regime for digital assets only coming into effect by mid-2026. Despite that, he frames the challenge as deeply rewarding — building a business from zero in a nascent industry with no playbook, bootstrapped the entire way, with the goal of becoming a digital-era complement to the likes of Charles Schwab or E-Trade. The episode closes with Bisher's market outlook: he sees Bitcoin within 10 to 20 percent of its bottom, expects three to four months of sideways chop, and is watching large institutional buyers accumulate aggressively at current levels ahead of what he believes will be a run toward $200,000 and beyond. Supporting links Stormrake Stabull Finance Andy on X Brave New Coin on X Brave New Coin If you enjoyed the show please subscribe to the Crypto Conversation and give us a 5-star rating and a positive review in whatever podcast app you are using.

Hoy arrancamos con Ciary Week, que claramente todavía no se acaba. Lo que parecía un toallazo ahora se complica cuando Justicia pide 90 días adicionales para investigar… y entra en escena el licenciado Antonio Sagardía.Luego analizamos una nueva encuesta de boricuas en Florida, que trae datos interesantes sobre economía, estatus y las prioridades políticas de esa comunidad clave.También discutimos la convocatoria para crear un nuevo partido político en Puerto Rico, quiénes están detrás de la iniciativa y qué posibilidades reales tiene.En el Patreon hablamos de la escuela de los ricos en Dorado, el modelo educativo que están vendiendo y lo que hay detrás del discurso de innovación.Si quieres escuchar el análisis completo y el contenido exclusivo:

Send a textIn this episode of Oh That's Cool, we're pawsitively excited to welcome Amethyst Ditieri, the Director of Student Success at Ozarks Technical Community College and a true cat-alyst for helping students find their path. Amethyst shares how she's been purr-suing student success, guiding future OTC students through the admissions process and helping them land on their feet as they begin their college journey.We also curl up with the story of how Amethyst once pounced on an opportunity to study abroad in Scotland, exploring how that experience shaped her perspective on education, independence, and discovering new horizons. Like any curious cat, she followed her instincts across the pond and returned with stories and lessons that continue to influence her work with students today.Back at OTC, Amethyst is leading the charge on a brand-new onboarding program designed to help students feel welcomed, supported, and ready to pounce on their goals from day one. From helping students navigate admissions to creating systems that make the transition into college smoother, Amethyst is always on the prowl for ways to improve the student experience.So settle in, grab a cozy spot, and join us for a conversation full of curiosity, opportunity, and a few purr-fectly placed cat puns along the way. It's a claw-some look at how one leader is helping OTC students start their college journeys on the right paw. 

In this episode of BRAVE COMMERCE, Rachel Tipograph and Sarah Hofstetter sit down with Dipesh Patel, Senior Director, Digital Transformation & Ecommerce, Global OTC at Teva Pharmaceuticals, to discuss what it takes to drive transformation in a category where trust, accuracy, and regulation shape the pace of change. Dipesh shares how his background in mathematics and early experience in retail influence his approach to problem-solving, ambiguity, and digital transformation.They also explore Dipesh's move from Unilever to Teva, including the difference between operating in a mature consumer goods environment versus building capabilities in OTC. The conversation also dives into AI's role in content creation, why speed alone isn't enough in healthcare, and how brands can use stronger systems and guardrails to scale content while maintaining control.Key takeawaysAI can scale content production, but strong guardrails and human oversight remain essential.In healthcare and OTC, brands must balance digital speed with trust and regulatory rigor.Building digital capabilities from scratch requires a different mindset than optimizing mature systems. Hosted on Acast. See acast.com/privacy for more information.

Send a textA quiet decision to start a resource for local patients turned into a milestone worth pausing for: 250 episodes dedicated to the craft and heart of hearing healthcare. We look back at where it began—growing up in a family clinic, falling in love with music and audio engineering, and studying communication sciences—and how those threads wove into a platform that champions people, not just products.We share the moment that still anchors our work: a patient who had stopped going out to dinner because conversation was too hard, and the smile that returned after a careful fitting and follow-up. That story embodies our stance on what moves outcomes: best practices like video otoscopy, tympanometry, OAEs, speech-in-noise testing, and real ear measurement, paired with counseling that meets patients where they are. Along the way, what started as consumer education expanded as clinicians, researchers, and innovators joined in, turning interviews into a living record of how standards evolve and lives change.We spotlight three pillars that guide us now. First, supporting providers by amplifying the clinical routines that sharpen results and reduce trial-and-error. Second, educating consumers so they walk into appointments ready to ask for objective measures and personalized fitting. Third, building community through a thought leader coalition—voices like Dr. Gyl Kasewurm, Dr. Jasen Ruiz, and Madison Levine, BC-HIS—who bring fresh perspective to verification, counseling, and the link between hearing and brain health. We also explore where the field is headed: AI that enhances, not replaces, clinicians; remote care that extends reach; and OTC devices that expand access when paired with clear guidance.If you care about hearing technology, patient outcomes, and the human connection that ties them together, you're in the right place. Share this milestone with a colleague, send it to a friend who's on the fence about a hearing test, and help us keep raising the standard of care. Subscribe, leave a review to tell us what you want next, and pass it on to someone who needs to hear life's story again.Read the full AudiologyOnline interview here about how AI won't replace the hearing care professional, it will enhance them! Visit our website and take our quick online hearing screener. And if you're ready to take the next step, our online hearing care provider locator can help you find a trusted hearing care professional near you. Taking that first step can make a meaningful difference, helping you stay connecting to the people and moments that matter most.  Connect with the Hearing Matters Podcast TeamEmail: hearingmatterspodcast@gmail.com Instagram: @hearing_matters_podcast Facebook: Hearing Matters Podcast

How are over-the-counter (OTC) hearing aids evolving as the market continues to develop? This week, host Bob Traynor speaks with David Hogan, Managing Director of ELEHEAR, about the growth of the OTC category and how new technologies are shaping consumer hearing solutions.Hogan brings more than 30 years of experience in audio wearables and hearing technology, including previous roles with GN and early wearable audio startups. In the conversation, he explains how ELEHEAR approaches hearing devices as a company rooted in sound processing algorithms and audio technology, and how that foundation has influenced the development of its OTC hearing products. The discussion also explores how features like Bluetooth connectivity, lifestyle audio functionality, and new earbud-style designs are expanding the role hearing devices can play in everyday life. Traynor and Hogan also discuss how OTC products may serve as an entry point for hearing care, helping more people begin addressing hearing challenges earlier while complementing traditional clinical pathways.For more information about ELEHEAR and the company's OTC hearing aid lineup, visit: https://elehear.com/Be sure to subscribe to our channel for the latest episodes each week and follow This Week in Hearing on LinkedIn, Instagram and X.- https://x.com/WeekinHearing- https://www.instagram.com/thisweekinhearing/- https://www.linkedin.com/company/this-week-in-hearingVisit us at: https://hearinghealthmatters.org/thisweek/

In this groundbreaking episode of the Tick Boot Camp Podcast, we interview Dr. Jayakumar Rajadas, a Stanford Medicine researcher who has discovered multiple breakthrough therapeutic candidates for Lyme disease, Babesia, and Bartonella. His work includes the discovery of Disulfiram's effectiveness against Lyme and Babesia, Azlocillin's potent activity against Lyme and Bartonella, and advanced targeted drug-delivery systems designed to preserve the gut microbiome. Dr. Jay's research has been featured in TIME Magazine (Azlocillin) and Forbes (Disulfiram), and connects deeply with the work of leading Lyme researchers, including Dr. Monica Embers (Tulane), Dr. Kim Lewis (Northeastern), Dr. Kenneth Liegner, and Dr. Brian Fallon (Columbia University). This interview delivers hope, science, and unprecedented detail on what may become the next generation of Lyme disease treatments. Key Topics Covered 1. How the Stanford Tick Initiative Sparked a New Era of Drug Discovery In 2012, Stanford launched a major initiative in response to community demand for better Lyme treatments. Dr. Rajadas was selected to lead drug development, focusing specifically on persistent/chronic Lyme disease, where few researchers were working. 2. Understanding Borrelia: Active vs. Stationary Forms & Why Chronic Lyme Persists Dr. J explains the three key survival modes of Borrelia burgdorferi: Active Phase The bacteria are replicating and metabolically active. Easier to kill with standard antibiotics. Stationary Phase Bacteria reach population limits and slow down growth. Represents early persistence mechanisms. Persister Forms Triggered by stressors like antibiotics (e.g., doxycycline). Bacteria fold into round bodies, spiral forms, or compact “cement-like” protective balls. These forms: Shut down metabolic pathways Resist penetration Survive antibiotic exposure Why Doxycycline Can Fail Doxycycline can induce persisters, causing Borrelia to form impenetrable protective shells rather than die. This is why many patients initially feel better, then relapse. 3. Disulfiram (Antabuse): Lyme + Babesia Breakthrough Featured in Forbes One of the biggest scientific shocks of the last decade: Discovery Through Stanford's high-throughput screening of FDA-approved drugs, Disulfiram emerged as a top hit. Clears Borrelia (including persistent forms) Clears Babesia — a major advantage over standard antibiotics Does NOT harm the gut microbiome Is already FDA-approved and widely used for alcohol aversion therapy Highly potent but requires careful dosing due to side effects in inflamed patients. Why Some Patients Improve, and Others Suffer Chronic Lyme patients already have heightened inflammation. Disulfiram is a powerful molecule whose polymorphic forms behave differently in different people. His lab developed: Less toxic formulations Buccal & sublingual delivery systems Rectal delivery options These may reduce neuropsychiatric side effects reported by some patients. Clinical Connections Dr. Kenneth Liegner pioneered clinical use and published cases Dr. Brian Fallon conducted NIH-listed clinical trials. Many clinicians now use Liegner's protocols. Real-world example: Matt shares the story of Brooke Stoddard (Generation Lyme), who regained his life after Disulfiram treatment under Dr. Liegner. 4. Azlocillin: The Antibiotic That TIME Magazine Called a Gamechanger If Disulfiram is the Lyme and Babesia weapon, Azlocillin may be the frontline tool for Lyme and Bartonella. Why Azlocillin Is Revolutionary Eradicates both active and persister forms of Borrelia. Destroys doxycycline-induced “cement ball” persisters by drilling into their vulnerable cell-wall synthesis pathways. Proven effective against Bartonella when paired with azithromycin, based on research by Dr. Monica Embers (Tulane) . The Cell-Wall Vulnerability Breakthrough Persisters STILL must maintain minimal cell-wall synthesis to survive. Azlocillin exploits this tiny vulnerability: It penetrates the protective sphere Breaks the “cement wall” Forces the bacteria out of hibernation Kills them rapidly This discovery is one of the biggest scientific leaps in Lyme research in a decade. The Delivery System That Protects the Gut Microbiome Azlocillin is extremely hydrophilic, making absorption difficult.Dr. Jay fixed this by creating: A magnesium-lipid nanoparticle formulation Designed to release in the upper intestine Avoiding the colon (where most microbiome lives) This allows: High bloodstream absorption Minimal microbiome damage Oral availability of a drug previously only available via IV Why Azlocillin May Be Better Than Disulfiram Hits Borrelia + Bartonella Stronger anti-inflammatory effects No polymorphism issues Fewer side effects Potent against persisters A company is preparing to bring his oral formulation to clinical trials by next year. 5. Loratadine (Claritin): The First Clue from 2012 Before Disulfiram and Azlocillin, Dr. Jay's lab identified Loratadine (Claritin) as a manganese transporter inhibitor of Borrelia. Why it mattered: Borrelia uniquely relies on manganese, not iron. Blocking manganese uptake may weaken the bacteria. The discovery went viral, with many patients reporting improvement even at OTC doses—though the binding affinity was weak. This project introduced the concept of drug repurposing for Lyme to the scientific community. 6. Melittin (Bee Venom) — The Micro-Needle Patch Alternative Bee venom therapy is widely used in the Lyme community, but risks stings and allergic reactions. Dr. J is developing: Melittin micro-needle patches Delivering the active peptide without stinging Using dissolvable, painless needles A safe, controlled, pharmaceutical-grade delivery approach This could modernize bee venom therapy and make it more accessible. 7. Mechanism of Brain Fog & Fatigue in Lyme: A Major Breakthrough Dr. Jay's lab published a neuroscience paper demonstrating: Outer Surface Protein (Osp) Nanoparticles Borrelia sheds lipid-coated outer membrane particles. These form stable nano-vesicles that: Enter the bloodstream Cross into the brain Cause mitochondrial dysfunction Reduce ATP production Result: Brain Fog, Fatigue, Cognitive Dysfunction This explains why neurological Lyme can persist even after bacterial levels drop. This work ties strongly to ongoing research at Columbia University under Dr. Brian Fallon. 8. Collaborations With World Leaders in Lyme Research Dr. J's research intersects with: Dr. Kim Lewis (Northeastern University) Reproduced and validated Disulfiram findings publicly. Helped launch interest in persister-killing therapies. Dr. Monica Embers (Tulane University) Demonstrated Azlocillin + Azithromycin effectiveness against Bartonella. One of the world's foremost experts in persistent infection models. Dr. Kenneth Liegner Early clinical pioneer of Disulfiram therapy. Published stunning recovery cases. Dr. Brian A. Fallon (Columbia University) Leading psychiatrist specializing in post-treatment Lyme. Conducted planned Disulfiram clinical trials. These collaborations form a powerful network accelerating treatment development. 9. New Anti-Inflammatory Discoveries: Galangin & More Dr. Jay recently co-authored a 2025 paper on: Galangin (Thai ginger rhizome extract) Which may reverse cardiac inflammation and fibrosis His team is also exploring other nutraceutical molecules for chronic inflammation relief in Lyme patients. 10. Dr. Jay's Personal Story of Illness and Hope He reveals for the first time: He was diagnosed with Stage 3 Multiple Myeloma Lost the ability to walk Suffered unbearable pain After cutting-edge therapies and research, he is now in full remission His message to Lyme patients: “There is ALWAYS hope.”

Walker sits down with Rational Root for a deep dive into Bitcoin's current market structure, bear market vibes, and why this cycle has felt so different, and whether the four-year cycle is still intact. Root argues Bitcoin is in a bear market phase, explains why institutional adoption and ETF flows created a more distributed top instead of a classic parabolic blow-off, and lays out why the next few months may look more like bottom formation than immediate breakout. They discuss the role of long-term holder distribution, why 100k became such a major psychological level, how business cycles and halving cycles interact, and why Bitcoin remains massively bullish long term even if price chops lower in the near term. Five key topics we discuss Why Rational Root believes Bitcoin is currently in a bear market, not just a mid-cycle dip How ETF flows, OTC buying, and institutional adoption changed this cycle's price action Why 100k became a major psychological sell zone for long-term holders and OG whales Whether the four-year cycle is still alive, and how much of it is really driven by the broader business/liquidity cycle Why Root remains extremely bullish long term even while expecting more chop and possible downside in the near term FOLLOW ROOT: X: https://x.com/therationalroot Nostr: https://primal.net/p/nprofile1qqsphh4hcsk9trquc2rd0drwge9vh75rmaa43xru4ha74nyrld9emyg4vj6zg WEB: https://www.bitcoinstrategyplatform.com/ PARTNERS & DISCOUNTS: LEDN: Bitcoin-backed lending. Go to ledn.io/walker and unlock liquidity WITHOUT selling your bitcoin. BLOCKSTREAM JADE: BLOCKSTREAM JADE HARDWARE WALLET: Head to https://store.blockstream.com/ and use coupon code WALKER for 10% off! BDIC™ is building an insurance marketplace on the bitcoin standard. Sign up for the waitlist at: http://bdic.io/walker Buy Bitcoin with River: http://partner.river.com/walker GET FOLD ($10 in bitcoin): https://use.foldapp.com/r/WALKER JOIN THE SUBSTACK TO GET NEW EPISODES DELIVERED STRAIGHT TO YOUR INBOX: https://walkeramerica.substack.com/ If you enjoy THE Bitcoin Podcast you can help support the show by doing the following: FOLLOW ME (Walker) on @WalkerAmerica on X | @TitcoinPodcast on X | Nostr Personal (walker) | Nostr Podcast (Titcoin) | Instagram Subscribe to THE Bitcoin Podcast (and leave a review) on Fountain | YouTube | Spotify | Rumble | EVERYWHERE ELSE

This week the sisters tackle a truly unexpected dilemma: what do you do when the pet you're babysitting dies on your watch? The conversation spirals into backyard burials, reptile drama, and the anxiety of being responsible for someone else's pet. Then a nurse practitioner joins the conversation to break down the growing trend of over-the-counter continuous glucose monitors and what they actually tell you about metabolism, weight, and midlife health. Plus: a dog destroys a beloved cashmere poncho and the sisters ask—what would you do?threelilfishes.com/shownotes for recipes and more details

🧭 REBEL Rundown 🔑Key Points Try the coffee nap! Where you combine caffeine and a 30-minute nap to then have that boost energy and alertness by the time it kicks in.💤 Sleep isn’t optional—it’s crucial for memory, mood regulation, and physical recovery. It is fundamentally different from rest❌ Replacing sleep with caffeine isn’t effective and can have negative health impacts. Make getting enough sleep a priority🌞 Sunlight exposure is important for maintaining circadian rhythms and sleep quality. This applies even if you work as a nocturnist💡 Creating a personalized sleep system enhances quality and consistency. It gives you back control of a schedule that you may feel like is out of your hands.🧩 If you’ve tried these strategies and you’re still struggling, consider true sleep pathology (insomnia, shift work disorder, sleep apnea) and get help—this is not a “be tougher” problem.🩺 Better sleep isn’t just about feeling good; it’s directly tied to error reduction, patient safety, and longevity in EM/ICU careers. Click here for Direct Download of the Podcast. 👀Previously Covered and Related Content: REBEL Core Cast: Sleep HygieneREBEL MIND: Rest Is Not Sleep: The Seven Dimensions of True RecoveryRebellion in EM: Care For Yourself – Sleep HygieneFirst10EM: Some Evidence For Working Night ShiftsREBEL MIND: Dunning Kruger Effect 📝 Introduction Welcome to this episode of REBEL MIND, where MIND stands for Mastering Internal Negativity during Difficulty. Here we sharpen the person behind the practitioner by focusing on things that improve our performance, optimizing team dynamics and the human behavior that embodies the hidden curriculum of medicine. Today we are exploring the imperative topic of rest and why it’s not just about sleeping. The second of a two part series, hosted by Dr. Mark Ramzy with guests Dr. Maureen Aiad and Dr. Amil Badoolah, continue our discussion but this time on the multifaceted nature of sleep, how it serves as medicine and how we can use our tools deliberately to get more of it! Cognitive Question How would your clinical performance, patience with families, and long-term career sustainability change if you treated sleep as a non-negotiable clinical intervention rather than a flexible “nice-to-have”? 💤How is Sleep Different From Rest? 1. Rest reduces load; sleep repairs systemsWe previously talked about the 7 types of rest and you can check that out hereExamples of physical rest include: pausing tasks, stepping away from the monitor, taking a walk, stretching, breathing, journaling, connecting with a colleague. This lightens your cognitive/emotional burden.Sleep is fundamentally different in that it’s an active biologic process that helps:Consolidates memory and learning (yes, including the tough cases from last night).Regulates mood, impulse control, and emotional reactivity.Supports immunity, metabolic health, and cardiovascular function.Repairs tissue, replenishes neurotransmitters, and fine-tunes neural networks.You can have “rested but underslept” days (you took breaks but got 4 hours in bed), and “slept but unrested” days (you got hours, but all junk sleep). Both matter, but they are not interchangeable.2. Sleep architecture vs. “knocking out”True restorative sleep cycles through NREM and REM in predictable patterns.Alcohol, late caffeine, and fragmented nights may help you fall asleep faster but:Suppress REM.Shorten deep sleep.Increase awakenings and light sleep.The result: you technically slept, but your brain didn’t get the “software updates” it needed.Biology isn’t built for your scheduleCircadian rhythms were designed for light-day / dark-night cycles, not:10 pm–7 am ED shifts.24-hour calls.6 nights in a row followed by days.Your body can adapt partially, but not instantly and not perfectly. That’s why:You can feel “jet-lagged” even when you haven’t traveled.Sleep before and after nights feels odd and fragile.Recognizing that “this is biologically unnatural” is key: you’re not weak; you’re fighting physiology. 🏥How This Applies to the Emergency Department or ICU? Performance & safetySleep deprivation:Slows reaction time and increases error rate.Impairs risk assessment and complex decision-making.Drops your frustration tolerance with consultants, families, and staff.In both emergency medicine and critical care, that translates into:Anchoring on the wrong diagnosis.Missing subtle clinical changes.Snapping at a tech, nurse or resident and damaging team culture. Chronic health for chronic shift workLong-term sleep disruption is associated with:Hypertension, diabetes, obesity.Depression, anxiety, burnout.Arrhythmias (e.g., AFib) and increased stroke risk.Possibly increased all-cause mortality.You’re already in a high-stress, high-exposure specialty. Chronically poor sleep amplifies that risk profile and can end a career early—or make you miserable while you’re still in it.Culture of “heroics” vs. healthSkipping sleep to pick up extra shifts, late meetings, or “just one more note” is often praised.We rarely celebrate:The attending who says “no” to a 2 pm meeting post-nights.The resident who defends their blackout-curtains-and-earplugs routine. 🛏️Different Ways to Improve Your Sleep Clarify your “sleep non-negotiables”Decide how many hours you realistically need to function (e.g., 7–9 on off days, realistic blocks on nights).Treat those hours as you would a procedure time—blocked, protected, and respected.Use caffeine like a drug, not a reflexAim for ≤ 2 cups equivalent on most days.Avoid caffeine within 4–6 hours of your planned sleep time (remember: it can hang around up to 12 hours).Consider scheduling caffeine for:Early in the shift for alertness.Strategic “coffee naps” (see below), not late-night chugging.Respect alcohol’s impact on sleepRecognize that even small to moderate doses degrade sleep architecture.Avoid using alcohol as a “sleep aid”—you’ll fall asleep faster but sleep worse.If you do drink, separate it from bedtime and keep it modest.Optimize food and fluid timingHydrate consistently on shift, but taper fluids ~4 hours before bed to reduce nocturnal bathroom trips.Avoid heavy, spicy, or large meals within 2–3 hours of sleep to decrease reflux and discomfort.Plan a light, balanced “pre-sleep” snack if going to bed hungry keeps you awake.Move your body (but not right before bed)Regular exercise improves sleep depth and latency.Try to avoid intense workouts within 2 hours of bedtime.On shift: micro-movement (stairs, brisk walks between pods, quick stretch sessions) can help alertness without wrecking sleep later.Control light exposureMaximize sunlight or bright light after waking (even if that’s 3–4 pm after a night).Minimize bright light and screens before sleep:Dim lights.Use night mode/blue-light filters if you must scroll.For daytime sleep:Use blackout curtains, tinfoil, cardboard, or sleep masks.Yes seriously use tinfoil if you have to, we talk about it on the podcast episode!Aim for “I might be blind” darkness—so dark you can’t see your hand in front of your face.Dial in your sleep environmentCool room temperature (fan or AC if possible).White noise or sound machine to mask household/traffic noise.Earplugs and eye masks as needed.Bed used primarily for sleep (and sex)—not for charting, doom scrolling, or email.Strategic power napsKeep naps ≤ 20–30 minutes to avoid sleep inertia.Prefer early-afternoon or pre-night-shift naps.Coffee nap strategy:Drink a small coffee.Immediately lie down for a 20–30 min nap.Wake up as the caffeine kicks in, combining nap benefit + stimulant.Thoughtful melatonin useRemember melatonin is a hormone, not a vitamin gummy.Lower doses often work as well as (or better than) large OTC doses.Use it intentionally and intermittently, not as a crutch every night.Over-reliance may reduce your own natural production and its effectiveness over time.Build pre-sleep ritualsRepeated, calming habits signal your body it’s time to downshift:Warm shower, gentle stretching, or yoga.Guided breathing or body scan.Brief journaling or “brain dump” of tasks to get them out of your head and onto paper.Protect from pathologic patternsIf despite consistent effort you:Snore heavily, stop breathing, or gasp in sleep.Feel excessively sleepy driving home or at work.Cannot fall asleep or stay asleep for weeks to months.Consider evaluation for sleep apnea, insomnia, or shift-work sleep disorder with your physician or sleep specialist. ⏩Immediate Action Steps for Before/During/After Your Next Shift 1. **Before the Shift**: Plan a 20–90 minute nap before your first night shift (many clinicians find 3–5 hours earlier in the day is ideal).I treat ED and ICU shifts very differently. I always sleep 3-5 hours before my night shifts aiming for the full 5 (sometimes 6 or more) hours for my ED shifts because you always have to be “on”. Depending on the ICU I’m working in, I may have a bit more downtime so 3 to 5 hours is plenty.Set a caffeine plan: decide in advance when your last dose will be (e.g., none after 2–3 am if sleeping at 8–9 am).Tell your household, “This is my sleep block” and agree on a plan for kids, pets, deliveries, etc.On my calendar, I completely block off time called “Pre-call sleep” so no meetings can be scheduled and then put my phone in airplane mode2. **During the Shift** Hydrate early; taper fluids in the last 3–4 hours of your shift Eat something light but adequate; avoid “last-minute” heavy meals right before sign-out.Build in micro-breaks and movement: one or two short walks, a few stretches, even a quick stair run if safe.Get outside or near a window for a few minutes of light exposure if possible.3. **After the Shift**On the way home:Use sunglasses to reduce bright morning light if you’re aiming for sleep soon.Avoid “just checking” email or messages; shift into wind-down mode.At home:Do a brief, calming decompression (shower, light snack, 10–15 minutes of low-stimulation TV or reading).Make your room cold, quiet, and dark (blackout curtains, tinfoil/cardboard, white noise, fan).Put your phone on Do Not Disturb and physically place it away from the bed.On my calendar, I completely block off time called “Post-call sleep” so again no meetings can be scheduled and then I personally don’t just put my phone on Do Not Disturb but rather in airplane mode and WIFI OFF If you can’t sleep after ~20–30 minutes:Get out of bed, do something calming in dim light (breathing, gentle stretching, journaling).Return to bed when sleepy—this trains your brain to associate bed with sleep, not frustration. Conclusion Rest and sleep are both critical—but they’re not interchangeable. Rest helps you step out of the constant “on” of our jobs, while sleep is the biological intervention that restores your ability to show up safely and sustainably. Rest ≠ sleep. Rest reduces load; sleep repairs your brain and body. You need both, on purpose.As EM and ICU clinicians, we’re trying to perform formula-one-level medicine with engines that often only see half their maintenance. You won’t fix shift work. You can build a sleep system that respects your biology, your schedule, and your life at home.That system starts with valuing sleep, then prioritizing it, personalizing it, trusting the process when it’s imperfect, and actively protecting both your routine and your mindset. 🚨 Clinical Bottom Line Sleep is medicine. Shift work is biologically unnatural. Struggling does not mean you’re weak; it means you’re human fighting physiology. Use your tools deliberately. Caffeine, naps, light, food, movement, melatonin, and environment can be leveraged—or can quietly sabotage you. Build and defend a personalized sleep routine. Communicate it, normalize it, and protect it from casual encroachment. You can’t control every trauma, code, or admission—but you can control how seriously you take your own recovery. Your patients, your team, and your future self all benefit when you do. Further Reading Espie CA. The ‘5 principles’ of good sleep health. J Sleep Res. 2022 Jun; PMID: 34676592Solodar, J“Sleep hygiene: Simple practices for better rest.” Harvard Health, 31 January 2025 Link is HereSuni, E.“Mastering Sleep Hygiene: Your Path to Quality Sleep.” Sleep Foundation, 7 July 2025, Link is Here Meet the Authors Mark Ramzy, DO Co-Editor-in-Chief Cardiothoracic Intensivist and EM Attending RWJBH / Rutgers Health, Newark, NJ Maureen Aiad, DO Assistant Professor of Emergency Medicine NYU Grossman Long Island School of Medicine, New York Amil Badoolah, DO Assistant Professor of Emergency Medicine NYU Grossman Long Island School of Medicine, New York REBEL Core Cast 119.0 – Sleep Hygiene REBEL Core Cast 119.0 – Sleep Hygiene Click here for Direct Download of ... Read More The post REBEL MIND – How to Sleep When the World Says You Can't appeared first on REBEL EM - Emergency Medicine Blog.

In this episode of Cutaneous Miscellaneous, host Nicholas Brownstone, MD, welcomes Peter Lio, MD, to examine the role of over-the-counter (OTC) skin care in everyday practice. They discuss evolving perceptions of “drugstore” products, explore what “sensitive skin” may actually represent clinically, and review emerging data on polymer-based cleansing technologies designed to support barrier integrity. The conversation also highlights formulation science, including research evaluating moisturizers that combine hyaluronic acid, natural moisturizing factors, and essential lipids, as well as data suggesting improved quality of life when lightweight adjunctive moisturizers are paired with acne regimens. They also examine clinical findings from a study assessing structured OTC regimens before and after procedures and their impact on tolerability and irritation. Tune in to the episode for an evidence-informed framework for recommending OTC products with confidence and elevating everyday patient care as a resident or early-career dermatologist.

Danhausen makes an auspicious debut at Elimination Chamber, we're blowing shit up, Rhea gets stiff with Jade, Punk gets stiff with OTC, where does mania stand right now

Anhören, lachen, abstimmen! Von 1LIVE.

Anhören, lachen, abstimmen! Von 1LIVE.

Send a textWhat if hearing care felt as welcoming as shopping for your favorite frames—personal, stylish, and on your terms—without losing the steady hand of a clinician? We dive into the origin and design of BLUEMOTH'S hybrid model that merges direct-to-consumer convenience with prescription-grade audiology, built to reduce stigma while preserving quality.We revisit the turning point of 2017, when OTC legislation surfaced and many clinicians feared erosion of standards. Our perspective flips the narrative: the real competitor isn't other providers, it's the vast number of untreated people avoiding help. Drawing inspiration from brands like Gentle Monster and Warby Parker, we explore how identity and choice can transform hearing devices from symbols of loss into tools of self-expression. That mindset, combined with a boutique standard of care, shapes a pathway that starts privately online and progresses through a guided home trial—always with a hearing care professional in the loop.Step by step, Dr. Melanie Hecker (founder and audiologist) unpacks the customer journey: a discreet virtual consult to lower intimidation, clinical recommendations for prescription devices, and support that mirrors best-in-class brick-and-mortar practices. We compare price versus stigma, discuss why denial still blocks action even when costs drop, and show how thoughtful e-commerce design can open doors without compromising outcomes. If you're a clinician curious about scalable, patient-centered workflows—or a listener ready to explore better hearing without the waiting room—this story offers a clear, human roadmap.If this conversation challenged how you think about hearing care, share it with a friend, subscribe for future episodes, and leave a quick review to help more people find us.Connect with the Hearing Matters Podcast TeamEmail: hearingmatterspodcast@gmail.com Instagram: @hearing_matters_podcast Facebook: Hearing Matters Podcast

In today's episode, we chat to Shaun Bunn, Managing Director at Empire Metals, an AIM and OTC-traded exploration & resource development company who are developing Pitfield, an emerging giant titanium project in Western Australia.  We talk about titanium, a critical mineral the West desperately needs more of and dive into the scale and purity of the Pitfield discovery in Western Australia and the upcoming drill programme. Why its location and government backing matter, and what makes this deposit fundamentally different from most titanium projects worldwide. Most importantly, we discuss how that difference could give Empire a serious strategic advantage as secure supply becomes a global priority. KEY TAKEAWAYS The Pitfield project is described as one of the world's largest titanium systems, with a 2.2 billion-tonne mineral resource that covers less than one-fifth of the identified anomaly. Titanium is a critical mineral for the West, particularly for NATO defence and aerospace; currently, supply is heavily concentrated in China (60%) and Russia. Unlike 90% of the world's supply which comes from ilmenite, Pitfield consists of anatase and rutile in sandstone, which lacks common impurities like chrome or uranium. Because the minerals are already oxidised, they can be processed at lower temperatures (just over 100°C) without the intensive acid and energy requirements of traditional smelting. BEST MOMENTS "We've found what is clearly the world's largest titanium system on the planet... it probably represents at least a third of the world's total resource in one spot." "Titanium is as strong as steel and half the weight... but the concentration of supply sits in, firstly China—something like 60% of all the metal—and Russia." "Metals is one of the key cornerstones of the mining industry... you need innovation, you need courage amongst all things to tackle some of these projects." "It's like replicating the chemistry that's already happened over time, only trying to do it in 24 hours and not 600 million years." GUEST RESOURCES Website: https://www.empiremetals.com/ Contact: https://www.empiremetals.com/contact/ X: https://x.com/Empiremetalsltd LinkedIn: https://www.linkedin.com/company/empiremetals/ VALUABLE RESOURCES Mail:        ⁠rob@mining-international.org⁠ LinkedIn: ⁠https://www.linkedin.com/in/rob-tyson-3a26a68/⁠ X:              ⁠https://twitter.com/MiningRobTyson⁠  YouTube: ⁠https://www.youtube.com/c/DigDeepTheMiningPodcast⁠  Web:        ⁠http://www.mining-international.org⁠ CONTACT METHOD ⁠rob@mining-international.org⁠ ⁠https://www.linkedin.com/in/rob-tyson-3a26a68/⁠ Podcast Description Rob Tyson is an established recruiter in the mining and quarrying sector and decided to produce the “Dig Deep” The Mining Podcast to provide valuable and informative content around the mining industry. He has a passion and desire to promote the industry and the podcast aims to offer the mining community an insight into people's experiences and careers covering any mining discipline, giving the listeners helpful advice and guidance on industry topics.  This Podcast has been brought to you by Disruptive Media. https://disruptivemedia.co.uk/

Pirouette Pharma CEO Conor Cullinane returns to Inside Startup Investing to share the company's progress since its last Wefunder raise—spanning FDA engagement, IND planning, and major steps toward scalable manufacturing. Pirouette is building a disc-shaped, push-button delivery system for injectable medications—aiming to turn the “violent, error-prone” experience of legacy auto-injectors into something closer to the Staples Easy Button: push once, and the device handles the rest. Chris and Conor discuss why intimidation and usability are major barriers in today's injection landscape, how Pirouette is approaching OTC naloxone via a combination-product regulatory pathway, what a pharmacokinetic study looks like, and why Pirouette is investing in manufacturing capacity to support both commercialization and pharma partnerships.   Chapters  00:44 What Pirouette is building 03:42 Progress since last raise 06:26 FDA pathway explained 09:08 PK study + size/cost/timeline 13:07 Partnerships vs. standalone commercialization 16:15 Revenue timing + adoption expectations 20:12 Manufacturing scale plan 23:34 Founder “why” 26:07 Investor close

In this Retail Technology Spotlight Series episode from Omni Talk Retail, Chris Walton and Anne Mezzenga welcome back Grocery Dealz co-CEOs Matt Goynes and Micheal Waldroup to unpack the rapid national expansion of their real-time grocery price comparison app. Now live in 40 states, Grocery Dealz enables consumers to compare grocery prices across retailers in real time before they shop and even push their lists directly into Instacart for delivery. The conversation dives into how the platform works, how pricing data is sourced, why retailers are paying attention, and what price transparency means for the future of grocery. From over-the-counter medicine and alcohol price swings to retail media monetization and API partnerships, this episode explores how comparison shopping could reshape consumer behavior... just as it did in travel and gas. With grocery bills rivaling plane tickets in weekly spend, is price transparency the next major retail disruption? Key Topics Covered: •What Grocery Dealz is and why it exists •The 3-step user experience: search, substitute, compare •Categories covered beyond center store (including OTC meds & alcohol) •How real-time grocery pricing data is sourced •Retailers' response to price transparency •The Instacart integration and delivery convenience factor •How Grocery Dealz makes money (affiliate + retail media model) •Consumer adoption metrics and time spent in app •What's coming next: live coupons and national growth •Can price comparison truly change grocery shopping behavior? Connect with the Guests: Matt Goynes: https://www.linkedin.com/in/matt-goynes-65921368/ Micheal Waldroup: https://www.linkedin.com/in/micheal-waldroup-3a74b82b7/ #retailtech #grocerytech #pricetransparency #retailmedia #ecommerce #omnichannel #retailinnovation #retailpodcast #OmniTalkRetail

This week on the Out of State Hunter Podcast, host Chad Ryker sits down in Santa Fe with Chad Nelson (Licensing Operations Manager for New Mexico Department of Wildlife) to break down non-resident hunting opportunities in New Mexico and how the 2026 draw works at a high level. They explain New Mexico's three draw pools (resident, outfitted, and unguided non-resident) and why guided/outfitted applicants typically have better odds than unguided non-residents. The episode covers species-by-species opportunity—highlighting New Mexico's reputation for trophy elk, solid mule deer and Coues deer potential, plus premium but low-odds hunts for bighorn sheep and pronghorn. They also clarify the E-Plus private-land elk system, including the difference between ranch-only vs unit-wide authorizations and why it can get expensive. For unique “only-in-NM” experiences, they dive into oryx, ibex, and Barbary sheep, with ibex noted as one of the toughest hunts around and Barbary offering accessible OTC options in certain areas. Finally, they stress doing your homework on hunt codes, tag numbers, and deadlines, staying on top of harvest reporting requirements, and watching for potential rule/proclamation changes heading into 2027. Key Takeaways No preference points in New Mexico — every applicant has a true random chance each year. Outfitted pool (10%) usually offers better odds than unguided non-resident (6%), but requires a signed contract and added cost. Avoid party applications, especially when tag numbers are low — it can dramatically hurt your odds. Tag numbers matter — small quotas can make some hunts essentially impossible for non-residents. E-Plus private land elk licenses create opportunity, but prices are set by landowners and can be expensive. New Mexico offers rare, unique hunts like oryx, ibex, and Barbary sheep, with some OTC options available. Do your homework: verify hunt codes, watch deadlines (March 18), complete mandatory harvest reporting, and stay alert for 2027 rule changes.   New Mexico Wildlife Website - https://wildlife.dgf.nm.gov Instagram - https://www.instagram.com/nmdeptwildlife/ Previous Podcast - https://open.spotify.com/episode/3Bv8ihJiFnn1NmOGEhwC3T?si=IPYnRFq7RVKxrqW3StAKXw   Out of State Hunter Instagram - https://www.instagram.com/outofstatehunter/   #outofstatehunter #huntnewmexico #newmexicohunting #elkhunting #huntthewest

This episode features Ivanny Franklin, Managing Partner at MedSight Capital, who brings a wealth of experience from her background in molecular biology and her decade-long tenure at NAMSA. The conversation centers on the shifting paradigms of medical device investment, specifically how the industry is moving away from service-based models toward a focus on clinical outcomes.Etienne and Ivanny explore the critical intersection of global regulatory bodies—such as the NMPA in China and the FDA in the US—and the necessity of a cohesive clinical evidence strategy. Ivanny emphasizes that for startups, understanding market-specific data requirements is not just a regulatory hurdle but a fundamental component of commercialization and investor conviction.The discussion also dives into the "patient empowerment" movement, fueled by the convergence of wearables, AI, and at-home monitoring. Ivanny shares her bullish outlook on technologies that give patients control over their data, while acknowledging the tension this creates for physicians and the ongoing need for rigorous regulatory oversight to ensure safety and effectiveness.Key Timestamps[03:15] Global Regulatory Strategy: Insights into the NMPA (formerly CFDA) and why China requires in-country clinical evidence.[07:42] Leveraging Data: How to run a single clinical trial to satisfy multiple global regulatory bodies.[10:18] The At-Home Monitoring Shift: The rise of wearables and OTC testing in the wake of COVID-19.[13:45] The "Data Gap": Addressing the friction between patient-gathered data and physician adoption.[18:22] Investment Non-Negotiables: Why revenue-generating companies and clear regulatory classifications are key for MedSight Capital.[23:10] Diligence and Deception: The importance of honesty regarding reimbursement codes and 510(k) vs. PMA paths.[27:45] SPV vs. Hedge Fund Models: A breakdown of how Special Purpose Vehicles allow family offices to be nimble in MedTech.Quotes"FDA and NMPA, for example, are quite strict in clinical evidence coming from in-country... as a startup, you really need to understand can we run a single trial with multiple global sites to achieve clearance cohesively." - Ivanny Franklin"I'm an advocate for [at-home monitoring]. I do think that's the future. However, there is concern around what types of information should patients be receiving and how are they going to act on that information?" - Ivanny FranklinTakeawaysRegulatory is the Roadmap: An investment is often "de-risked" based on the clarity of the regulatory path. If a founder cannot distinguish between a 510(k) and a PMA, it is a major red flag for investors.Harmonize Your Trials: To achieve "economies of scale" in clinical evidence, work with consultants to design trials that meet the stringent requirements of both the FDA and international bodies like the NMPA early on.

Innovation doesn't need to (and usually shouldn't) be complicated. In fact, look at the recent Wonderbelly acquisition. It reimagined OTC medicine by moving beyond sterile branding, offering effective products with clean ingredients and enjoyable flavors…targeting health-conscious Millennials (and Gen Z) looking to make digestive relief a more positive experience. So, if you really want to create something that has lasting impact, it needs to be a combo of “new” yet “familiar.” And many of today's most successful CPG brands resulted from identifying that doing something too closely related to market leadership won't get noticed…but doing something too novel and it will create confusion.

Dr. Jess has specialized in patients with complex, chronic illness - people who had seen multiple practitioners and still had no solutions. He focuses on explaining Long Covid at the cellular level and how recovery is possible. He also advises taking Acetyl Glutathione as a powerful antioxidant and imperative for anyone taking OTC medication or prescription medication as Glutathione is robbed from the body as a result of med usage. DrJessArmine.com His book: "Leaky Gut, Leaky Cells, Leaky Brain" available on Amazon.com

Special Counsel Amelia McKellar joins us to explore merger control and microchips, industry policy and involution in the world's second-largest economy. Plus, all the news on the new and now mandatory Australian merger framework, G+T's new tool to navigate all those thresholds and forms, the proposed prohibition on unfair trading practices planned for 2027, and a whistleblower bounty in the US … All this and the accidental sad horse with co-hosts Moya Dodd and Matt Rubinstein.      Links:   ABC on Australia's Central Western Standard Time Zone (UTC+08:45) The Criterion Collection on the Once Upon a Time in China series The consolidated Notifications Determination and the Forms Determination G+T on the merger changes that came into effect in January 2026 Our new merger assessment obligation tool: MerTL Possibly the best book written on the subject of turtle stacking US Antitrust Division and US Postal Service pay $1m whistleblower bounty Check out our episode on whistleblowers with Kieran Pender from last September No-one's far from anyone anymore with the OTC in 1990 The Guardian on the accidental sad/crying horse Meet the Gilbert + Tobin Competition, Consumer + Market Regulation team Email us at edge@gtlaw.com.au Support the show: https://www.gtlaw.com.au/See omnystudio.com/listener for privacy information.

In Part 2 of HBW Insight's conversation with sustainability leader Steve Ramus, we dig into the practical realities shaping the future of sustainability in consumer health, from what consumers are actually willing to pay for, to why packaging, supply chains and long‑term planning remain some of the industry's toughest challenges. Drawing on two decades of sustainability and ESG experience, Ramus explains how consumer price sensitivity varies across markets, why sustainability can ultimately make companies more efficient, and how inflation complicates the conversation. We also explore the complex world of pharmaceutical packaging — where safety, stability and regulation often collide with expectations around plastics, recyclability and waste — and why progress, though slow, cannot stall. Timestamps: 2:00 – Will consumers pay more for sustainable OTCs? 7:00 – You don't want to be unsustainable 9:00 – ESG is good for business 10:00 – Retailer expectations 15:00 – The state of play in OTC packaging 20:00 – The challenge of replacing plastic 23:00 – The challenge of recycling 27:00 – Sustainability priorities right now 31:00 – Supply chain 32:00 – The life of a sustainability professional Guest Bio: Steve Ramus is a global sustainability and ESG executive with 20 years of experience aligning strategy with business growth, risk mitigation, and value creation. As former Vice President of Sustainability & ESG at Perrigo, he led: ESG reporting, climate strategy, responsible sourcing, human rights due diligence, packaging circularity, community engagement and other initiatives that improved ESG ratings, delivered cost savings, and generated millions in incremental revenue. Steve advanced his career within the business having led teams in both HR and Sales, prior to his roles in sustainability.

Crypto lawyer-turned-operator Daniel Lo shares an “alternative legal career” journey, sharing how he wen from M&A in Calgary to Managing Director, GM and CLO at Acheron Trading in Singapore. He explains what it's wearing both the legal and management hat, breaks down how a market maker supports token projects (from white-glove designated market making to execution/OTC), and what it takes to get regulated in 2026's tougher environment.Daniel also dives into why he co-founded LDU (Legal Disruption Unit) to help startups and crypto teams move beyond the traditional billable-hour model (much like we do at DLT Law) - especially around licensing, compliance, and regulator engagement. Finally, he shares practical AI workflows for legal/compliance teams (including how to turn regulator guidance into a checklist-based gap analysis), and gives an Asia-focused regulatory outlook on Singapore vs Hong Kong, plus what to watch in South Korea as institutional participation opens up.Connect with Daniel on LinkedIn.

Ripple Dropped a Major XRPL Upgrade — UK Backlash Grows | US Fraud Probes Intensify Ripple just dropped a major XRPL upgrade — and almost nobody is talking about what it really means. Token Escrow (XLS-85) is now LIVE on the XRP Ledger, extending native escrow functionality beyond XRP to issued assets, trustline-based tokens, Multi-Purpose Tokens, stablecoins like RLUSD, and Real World Assets. This isn't hype. This is institutional-grade infrastructure quietly expanding on-chain settlement power. At the same time: • Political backlash is intensifying in the UK • Governance debates are heating up • Fraud investigations in the United States are gaining momentum As decentralized financial rails strengthen, public trust in traditional institutions is being tested. Is this just coincidence — or are we watching a larger shift unfold? In today's episode of **On The Chain**, we break down:

XRP Slides | Crypto Tears | Epstein Fallout & 2020 Election Questions Return XRP is sliding as crypto market tension builds — but is this short-term volatility or something bigger unfolding beneath the surface? In today's episode, we break down: • Why XRP is under pressure • What's happening with broader crypto markets • Ripple's positioning in the current regulatory climate • The latest fallout surrounding newly discussed Epstein files • Why 2020 election debates are resurfacing again The digital asset market is navigating uncertainty, shifting narratives, and political crosscurrents. While XRP experiences downside movement, institutional conversations around regulation, transparency, and accountability continue to evolve. On the political side, recently discussed documents tied to the Epstein investigation have reignited public debate — and election integrity conversations from 2020 are again entering the national discourse. We're not here for slogans. We're here to break down the narratives, the data, and the tension driving headlines. Drop your thoughts below: Is XRP's slide a setup? Are political narratives shifting? What matters most to you right now — crypto or policy?

What if advanced AI noise reduction could run efficiently on standard hearing device hardware?In this episode, Dave Kemp speaks with Aernout Arends of Absolute Audio Labs and Zengyi “Boltzmann” Li of Aizip about how platform-based hearing architectures and tiny AI models are reshaping the future of hearing technology. The discussion centers on the integration of Aizip's AI-driven speech and noise separation into AAL's PYOUR Audio framework, enabling advanced hearing performance across multiple hardware platforms without requiring specialized processors.The conversation explores how AI-based denoising differs from traditional approaches, particularly in complex real-world listening environments, and how open platform ecosystems may accelerate innovation by allowing specialized technologies to integrate more efficiently into complete hearing solutions. Looking ahead, the discussion considers how these advances could expand access, improve speech understanding in noise, and help drive the next generation of hearing devices across both prescription and OTC markets. Be sure to subscribe to our channel for the latest episodes each week and follow This Week in Hearing on LinkedIn, Instagram and X.- https://x.com/WeekinHearing- https://www.instagram.com/thisweekinhearing/- https://www.linkedin.com/company/this-week-in-hearingVisit us at: https://hearinghealthmatters.org/thisweek/

Sleep doesn't break because you forgot how to close your eyes. It breaks when anxiety trains your brain to stay on guard, and when quick fixes like alcohol, cannabis, or OTC sleep aids sedate you without restoring you. We team up with Australian psychologist and author Helen Dugdale to unpack how insomnia forms, why 3 a.m. wakeups become a habit loop, and the practical, evidence‑based steps that rebuild real rest—especially for people in recovery.Helen shares how anxiety sits at the core of most sleep problems and why the brain's plasticity is our greatest ally. We dig into Cognitive Behavioral Therapy for Insomnia (CBT‑I) basics—aligning with circadian rhythm, setting simple pre‑bed routines, and replacing catastrophic thoughts with repeatable behaviors—and explore how Eye Movement Desensitization and Reprocessing (EMDR) calms trauma so sleep skills can finally land. Expect concrete tactics: caffeine cutoffs tied to bedtime, screen boundaries that don't feel punitive, mantras that redirect attention, breathing and counting that occupy mental space, and progressive muscle relaxation you can run anywhere, even in a noisy room with the lights on.We also address the realities people with addiction face: unstable housing, tight budgets, caregiving, and long days that drain executive function. You'll hear how to build micro‑habits that fit into crowded lives—thirty seconds while the kettle boils, one minute before starting the car, seven minutes as “0.5% of your day.” We talk timelines for progress, what to do on rough days when HALT hits, and how to bounce back from relapse without shame. The throughline is hope: you are worth the effort, and repetition rewires nights. If you're ready to trade quick fixes for deep, durable rest, this conversation gives you a blueprint you can start tonight.Subscribe, share with a friend who needs better sleep, and leave a review with the one habit you'll try first. Your feedback helps others find the show.To learn more about Helen's work: https://australianbraincoaching.com.auTo contact Dr. Grover: ammadeeasy@fastmail.com

XRP Locking In | ETF DeFi RLUSD | Politician Corruption XRP continues to lock in real infrastructure while markets and politics remain volatile. In today's episode of On The Chain, we break down: -The return of XRPL TipBot with self-custodial tipping -Ripple's institutional DeFi blueprint positioning XRP as a settlement and bridge asset -XRP ETFs hitting record adoption -RLUSD growth and real-world asset expansion on the XRP Ledger -Key insights from the latest MessariCrypto report -Why mindset matters, according to Brad Garlinghouse We also zoom out to examine political corruption, government overreach, and why centralized systems tend to tighten control right before trust breaks.

Bum N Zilly are back with the Royal Rumble review! OTC! Tribal Chief Roman Reigns 00:17 "Ones to the Sky"03:22 Show intro 05:36 Show comments and bad production at the Rumble 08:47 Show preview and the Wasted Management Open11:42 The 39th annual Royal Rumble Review 41:20 The Sabres report 48:33 Lakers dominate the Wizards 50:24 NBA trade transactions 52:38 Lakers get smoked in New York but dominate the Nets 56:11 Super bowl preview 58:35 Bum gets distracted (Zilly goes solo) SB first TD and halftime1:01:41 The Ozzy grammy tribute and the Ixnay on the Hombre anniversary 1:04:29 Show Outro          Want to get your thoughts involved with the podcast?Check us out on Twitter/X @BumNZillyshowEmail at bumandzillyshow@gmail.com

Ripple + Hyperliquid | Celebrities Get Wrecked | Governor Race Heats Up SUPPORT ON THE CHAIN GRAB A BADASS YETIS COFFEE – Fuel your crypto grind! ☕ Visit: otc.one/BadassYetisBrew MINT YOUR BADASS YETIS NFT – Own a piece of the legend! Visit: otc.one/mint OTC MERCH IS HERE! – Represent the community in style! Visit: onthechain.shop BUY US A COFFEE – Help keep the content flowing! Visit: otc.one/buy-us-a-coffee JOIN THE CHANNEL – Get exclusive perks & behind-the-scenes content! Visit: otc.one/join ********** ON THE CHAIN – CONNECT WITH US! Listen to the OTC Podcast – Never miss an update! Visit: otc.one/podcast Visit Our Website – The home of crypto insights! Visit: onthechain.io Follow OTC on Twitter – Stay updated in real time! Visit: otc.one/otc Join the OTC Community on Twitter – Be part of the discussion! Visit: twitter.com/i/communities/1599435678995062788 ********** FOLLOW THE OTC TEAM Follow Jeff on Twitter:

Mitochondria, Metabolism & Modern Medicine   When "Everything Looks Normal"… But You Don't Feel Normal The Cellular Health Conversation Most People Never Get Why Your Energy, Hormones, and Metabolism Start at the Mitochondria   You can be "doing everything right"… and still feel wiped out by 2 p.m.  You can have "normal" labs… and still feel like something is off.    In this episode of Richer Soul, Rocky sits down with Dr. William Haas to explore what modern medicine often misses: cellular dysfunction, mitochondrial health, gut integrity, hormones, toxins, and recovery tools like hyperbaric oxygen—especially for high performers who hit the wall despite clean living.  "Medical school is teaching how to manage disease. And that was a rude awakening."    5 Soul-Level Insights from Dr. William Haas: (This isn't about chasing more hacks. It's about understanding what your body is telling you.)  Mitochondria aren't just "energy." Dr. Haas explains mitochondria produce ATP (your energy currency) and influence inflammation and immune pathways—so mitochondrial dysfunction can ripple into far more than fatigue.  Some "normal" meds can quietly derail cellular performance. He specifically calls out antibiotics like Cipro and Levoquin as "terrible" for mitochondrial health, notes OTC anti-inflammatories can "uncouple" mitochondria, and discusses metformin potentially impacting mitochondria and contributing to B12 deficiency.  Food sensitivities may be a symptom, not the root cause. When people "light up like a Christmas tree" on food sensitivity testing, Dr. Haas says it often points to gut barrier issues ("leaky gut")—and that fixing the gut can make sensitivities go away.  Hormones don't fail in isolation—stress and sleep shape the outcome. He emphasizes starting with fundamentals like sleep, alcohol reduction, and stress management, and explains "cortisol steal" where high stress drives cortisol production at the expense of testosterone.  Metabolism isn't magic: build lean muscle. When asked how to increase metabolic rate, Dr. Haas gives the simplest (and most effective) answer: build lean muscle mass.    Why This Conversation Matters: Dr. Haas shares that in his 40s—while scaling his medical practice, starting another business helping other doctors, and growing his family—fatigue hit hard, even while he was "doing the right things." It became a wake-up moment that something at a cellular level was off.  That experience pushed him deeper into what he describes as cellular medicine: mitochondria, redox/repair pathways, hormones, toxins, and tools like hyperbaric oxygen.  And it highlights a hard truth for high performers: If your health collapses, your freedom collapses with it.    Money Learning: Dr. Haas also touches a reality most people don't think about: Becoming a doctor can delay earning for a long time. He says he was about 38 when he made his first "real" doctor paycheck—and contrasts that with his brother who started earning right after college.  Rocky adds an important point: sometimes the best decisions happen outside the traditional insurance-driven system—when you can get proactive testing and establish baselines, rather than waiting until the system says you're "sick enough" to qualify.    Key Takeaway: If you want more energy, better recovery, and a longer health span, you can't only focus on symptoms—you have to protect the foundations: mitochondria, gut function, hormones, and lean muscle mass.    Guest Bio: Dr. William Haas: Dr. William Haas is trained in family practice and describes his path into integrative medicine, which he frames as focusing on prevention, food as medicine, the mind-body connection, and pulling tools from different healing modalities. He also mentions training/mentorship with Andrew Weil.  In this episode, he discusses deeper evaluation beyond basic labs, including gut function/microbiome, micronutrients, hormones, inflammation, and toxins such as mycotoxins/mold, microplastics, and heavy metals.    Links: Website: https://vyvewellness.com/ Facebook: https://www.facebook.com/VYVEWellness/ Instagram: https://www.instagram.com/vyvewellness YouTube: https://www.youtube.com/@VYVEWellness Blog: https://vyvewellness.com/blog/   Ready to Go Deeper? Stop accepting "everything looks normal" as the end of the conversation. If you want to identify your own detox, redox, and repair blind spots, start with the free assessment at vyvewellness.com.   #RicherSoul #DrWilliamHaas #Mitochondria #MitochondrialHealth #Metabolism #LeanMuscle #FunctionalMedicine #IntegrativeMedicine #GutHealth #LeakyGut #HormoneHealth #Testosterone #HyperbaricOxygen #HBOT #Longevity #HealthOptimization    Watch the full episode on YouTube: https://www.youtube.com/@richersoul Richer Soul Life Beyond Money. You got rich, now what? Let's talk about your journey to more a purposeful, intentional, amazing life. Where are you going to go and how are you going to get there? Let's figure that out together. At the core is the financial well-being to be able to do what you want, when you want, how you want. It's about personal freedom! Thanks for listening! Show Sponsor: http://profitcomesfirst.com/ Schedule your free no obligation call: https://bookme.name/rockyl/lite/intro-appointment-15-minutes If you like the show please leave a review on iTunes: http://bit.do/richersoul https://www.facebook.com/richersoul http://richersoul.com/ rocky@richersoul.com Some music provided by Junan from Junan Podcast Any financial advice is for educational purposes only and you should consult with an expert for your specific needs.

In this episode, we react to Roman Reigns making his choice for WrestleMania! The main event is official, as we will see the OTC battle CM Punk for the World Heavyweight Championship! We also dive into what happened with the Women's Rumble winner, Liv Morgan and highlight the Royal Rumble takeaways you need to know. Also, we pay tribute to AJ Styles following his Royal Rumble defeat to Gunther, marking a potential end of an era. We'll relive the defining moments of Styles' storied WWE career, and what made him such an incredible talent.

In this episode of the Rokcast, Jaden Bales sits down with Aquila Brown, a BC hunter who flat-out earned a monster timber giant mule deer the hard way. This wasn't some glass-a-basin-and-pick-a-buck hunt. This was thick, steep, nasty timber on an over-the-counter tag, with almost no visibility and plenty of pressure. Aquila spent close to 20 days scouting and hunting one specific buck and made the decision early that he was either killing that deer or eating the tag. We dig into how he hunted mule deer where glassing barely works. Trail cameras became his eyes in the woods, snow tracks kept him in the game, and still-hunting was the only real way to make something happen. Aquila breaks down how slow is actually “slow enough,” how he handled missing the buck by hours or a couple hundred yards, and why believing the deer was still there mattered more than anything. If you hunt dark timber, pressured OTC units, or country that just feels hopeless most days, this episode will hit home. It all comes together on the very last day of the season with a fast, offhand shot through a tiny opening in the trees. We talk about passing good bucks late in the season, trusting the process, and what it feels like when everything finally clicks after weeks of grinding. This is a real look at killing a giant mule deer on purpose, not by luck, and why sometimes the hardest hunts are the ones that stay with you forever. Listen in to learn more about hunting a Timber Giant!   You can reach out to Aquila on Rokslide at Kootenaybackwoods at https://rokslide.com/forums/members/kootenaybackwoods.78840/ or discuss this episode here https://rokslide.com/forums/forums/rokcast.129/ You can find Robby's books, Hunting Big Mule Deer and The Stories on Amazon here or signed copies from the Rokslide store here

With the European Union rolling back parts of its Green Deal — including scaling back major legislation such as the Corporate Sustainability Reporting Directive and the Corporate Sustainability Due Diligence Directive — and the US splintering into state‑by‑state sustainability mandates, global OTC companies are facing a fresh wave of uncertainty around their sustainability strategies. It's no surprise, then, that many are acting and investing more cautiously. But for sustainability expert Steve Ramus, formerly VP for Sustainability & ESG at Perrigo, now is precisely when leadership matters most. Sustainability teams, he argues, should be helping their executives and boards see that doing the “right” thing is also the competitive thing. Companies that keep moving through the uncertainty, he says, will be faster, leaner and far better prepared than those waiting on the sidelines. Timestamps: 3:00 – Introductions 4:50 – The state of sustainability in consumer health 9:00 – The business case for sustainability 14:30 – Where are we heading? 17:20 – Making the case for sustainability within companies 20:30 – The chilling effect of uncertainty

XRP Reality Check — Iran Crisis, Europe at Breaking Point | Where Are We Wrong? In this episode, we take a hard look at three pressure points shaping the current global narrative: • XRP and crypto honesty — when rare moments of transparency raise bigger questions • Iran's ongoing crisis — rising death tolls and why global attention seems absent • Europe at a breaking point — political, demographic, and cultural stress lines This is not a hype show and it's not a doom show. It's a reality check. We walk through the clips, the history, and the contradictions — and then ask the most important question in any serious conversation: Where are we wrong?

En el episodio de hoy pusimos en el potro a la secretaria de Vivienda y el bono en la CEE. Luego, analizamos lo que dijimos que iba a pasar: "Ding Dong, la Reforma Contributiva is dead.” Explicamos qué pasó, quién jaló el freno de mano y por qué este proyecto terminó muriendo entre la espada de la Junta y la pared del PNP. Incluimos el momento de “poca humildad” donde Luisito lo dijo… y el tiempo le dio la razón.También tocamos el arresto de Don Lemon por el gobierno de Trump, y te contamos quién es el nuevo empresario estrella de JGo y su rol en salvar el empleo de la presidenta de la UPR Zayira Jordán.En el chit chat, Melania, MAGAbichos, Luisito Somalí y los papelones digitales que nunca fallan.--

XRP BREAK OUT | Global Reset | Institutions React | Regulation Tested The XRP ecosystem is entering a decisive phase. In today's episode, we break down why XRP is breaking out as the global financial system undergoes a major reset. From Ripple's accelerating institutional traction to critical developments around U.S. market structure legislation, regulation is no longer theoretical — it's being tested in real time. We cover: Why XRP's momentum is accelerating globally How institutions are responding behind the scenes What new market structure bills mean for crypto clarity Why regulation is now a catalyst, not a roadblock The growing role of XRPL and RLUSD in institutional markets As legacy systems strain under political pressure and legal uncertainty, capital is moving toward clarity, efficiency, and rails built for scale. This is not hype. This is structure meeting reality.

Send us a textA quieter problem carries loud consequences: when hearing loss goes untreated, risks rise for cognitive decline, cardiovascular strain, and falls. We pull that chain into the light and show how one change—adopting hearing technology earlier—can shift the long‑term outlook. With better devices, rising satisfaction, and less stigma, the path to clearer sound and stronger health is getting shorter and friendlier.We walk through fresh insights from MarkeTrak 2025, including how consumers perceive prescription hearing aids, what over‑the‑counter devices get right, and where they fall short. The data is clear: satisfaction is high across the board, but loyal users value the guidance of a hearing care professional, especially for the hardest tasks—accurate assessment, the right device selection, and real troubleshooting. We explore why counseling and expectation setting matter as much as hardware, and how theory of mind helps clinicians solve problems that algorithms miss, like clarity in noise and the fatigue of constant listening effort.Access still matters, and OTC can be a smart on‑ramp—if it connects people to support when they need it. That's where community steps in. Friends, family, and colleagues influence the first move, while clinics can demystify the journey with quick, transparent demos of an annual hearing test. We share practical ways to normalize hearing care as part of total well‑being—physical, emotional, and mental—so taking action feels positive and routine. Ready to rethink hearing health as preventive care you can feel every day? Follow the show, share this episode with someone who needs a nudge, and leave a review to help more people find their way to better hearing.Connect with the Hearing Matters Podcast TeamEmail: hearingmatterspodcast@gmail.com Instagram: @hearing_matters_podcast Facebook: Hearing Matters Podcast

Send us a textPolicy shifts, lived experience, and modern tech meet in a conversation that makes hearing health feel urgent, hopeful, and actionable. We sit down with HIA executive director Bridget Dobyan to connect the dots between 2026 advocacy priorities, the real value of professional care, and what the latest MarketTrak 2025 data tells us about adoption, satisfaction, and consumer behavior. From state-level licensing updates after the OTC rule to federal student loan reforms that shape the workforce pipeline, we map a clear path for clinicians and consumers to navigate change with confidence.Bridget shares a practical playbook: invite lawmakers into your clinic during district work periods, show them the full care journey, and partner with AAA, ASHA, ADA, Listen Carefully and IHS to align messaging. We dive into why the timeline to seek help is shrinking, how satisfaction remains high for both devices and professionals, and why many OTC users say they would have benefited from clinical guidance on assessment, selection, and troubleshooting. This isn't theory; it's data-backed insight that reinforces the power of counseling, empathy, and real-world fine-tuning, even as AI tools evolve.You'll also hear how HIA's man-on-the-street campaign blends humor and education to make hearing health relatable at every age. A new mother finds comfort in newborn screening; a new hearing aid user lights up about Bluetooth streaming and wishes he hadn't waited. These stories counter fear with possibility, positioning hearing care as part of total health—supporting communication, safety, and cognitive well-being. If you're a clinician, you'll leave with steps to boost advocacy and awareness. If you're a listener on the fence, you'll see how earlier action leads to better outcomes.If this resonates, follow the show, share it with a friend who's been “waiting to hear better,” and leave a quick review with your biggest takeaway—we read them all.Omega AI hearing aids don't just keep up. They redefine what it means to be modern and discreet yet durable and comfortable for all-day wear.They're waterproof, everyday-proof, and designed to go the distance of your day and then some. All while tailored to your unique hearing needs. Connect with the Hearing Matters Podcast TeamEmail: hearingmatterspodcast@gmail.com Instagram: @hearing_matters_podcast Facebook: Hearing Matters Podcast

Send us a textS6 E115 - Breaking Up with OTC Sleep Aids and Tips and TricksIn this episode, Dan and Michelle discuss the challenges and strategies of weaning off over-the-counter (OTC) sleep medications. They explore the common OTC aids like diphenhydramine, alcohol, melatonin, and valerian root. Additionally, the hosts talk about the behavioral conditioning associated with sleep aids and provide actionable tips for breaking the cycle. Learn how to manage your sleep health better and reduce dependency on OTC sleep aids with practical advice from sleep experts.00:00 Welcome and Introduction00:10 Florida Weather and Electricity Bills01:21 Solar Energy and Political Opinions02:13 Property Taxes and Legal Issues02:39 Main Topic: Breaking Up with Over-the-Counter Sleep Medications04:04 Common OTC Sleep Aids05:19 Alcohol as a Sleep Aid07:25 How to Wean Off OTC Sleep Aids08:55 Behavioral Conditioning and Sleep10:48 Sleep Takeout Tip: Separating Bedtime from Medication11:57 Conclusion and Farewell✨ Real rest isn't just about falling asleep, it's about feeling at ease again. I'm Dr. Daniel Baughn, sleep psychologist and co-host of Sleep Takeout. I help professionals and high-achievers who seem to have everything together on the outside but can't quite turn off their minds at night.

You know the drill: Pop two ibuprofen at 6 AM. Save your prescription meds for the "really bad" days. Hope the over-the-counter stuff is enough to get you through. But what if the medication you're using to save yourself is actually keeping you stuck? On this episode of The Migraine Freedom™ Your Way podcast, I'm sharing the uncomfortable truth about over-the-counter pain medication-why daily use is masking (not ending) your migraines, and how my clients broke free from the OTC trap. In this episode, you'll hear: Why rationing prescription meds leads to OTC overuse and dependence The short-term and long-term dangers nobody talks about (rebound headaches, kidney damage, gut destruction) How all medication is toxic and lowers your migraine threshold by raising inflammation Real client stories: From daily medication to using it sparingly (and successfully) The difference between surviving with medication vs. thriving without needing it daily   Resources: FREE DOWNLOAD: Toxic Migraine Triggers Guide Get the complete guide showing you the hidden inflammatory triggers keeping your migraines alive-including toxins in your medication, environment, and everyday life.  The Freedom From Migraines Method® Learn more about addressing the root cause of your migraines so you can stop surviving with medication and start thriving.  Book a free Migraine Breakthrough® Assessment: https://pages.debbiewaidlcoach.com/breakthroughcall   Connect with Debbie: Instagram: https://www.instagram.com/debbiewaidlcoach Women's Migraine Freedom™ Facebook Group: https://urlgeni.us/facebook/Womensmigrainefreedomom Website: https://pages.debbiewaidlcoach.com/   Disclaimer: The Migraine Freedom™ Your Way Podcast and information provided by Debbie Waidl and guests in this podcast is presented solely to provide helpful information, education, and entertainment on the subjects discussed. The use of information or resources mentioned on or linked from this podcast is at the user's own risk and discretion. This podcast is not intended to diagnose or treat any medical condition. For diagnosis or treatment of any medical problem, consult your own physician. Debbie Waidl and In The Balance Health Coaching, LLC are not responsible for any medical conditions or liable for any damages or negative consequences from any treatment, action, application, or preparation to any person reading or following the information presented on this podcast. References are provided for informational purposes only and do not constitute an endorsement of any websites or other sources.  

Send us a textStruggling to catch every word or feeling like voices are loud but still muddy? We unpack the real differences between over-the-counter hearing aids and prescription fittings, focusing on when each path makes sense and how to get results you can actually feel in daily life. Drawing on clinical standards and FDA guidance, we map clear criteria for safe OTC use, the red flags that call for an audiologist or ENT, and why a baseline hearing test is one of the most valuable health checks you can get.We walk through what a prescription fit includes—diagnostic testing, individualized programming, and real-ear verification—so you understand how precise tuning translates into sharper speech clarity. Then we contrast that with self-fit OTC devices: accessible, affordable, and helpful for some adults with mild hearing loss, but limited by generalized amplification and lack of objective verification. You'll hear why noise is the top complaint across users, how directionality and signal processing drive comprehension more than raw volume, and how realistic expectations, coaching, and follow-up shape satisfaction.Along the way, a simple vision-care analogy brings the trade-offs to life: readers can help in a pinch, but complex needs benefit from a tailored prescription. We also look ahead at how AI is enhancing hearing care without replacing the professional, and how OTC options have expanded awareness while underscoring the value of expert guidance. If you're wondering whether to start with an OTC device or book a comprehensive evaluation, this conversation gives you the clarity to choose confidently—and the next steps to take.If this helped you make sense of your options, follow the show, share it with someone who's hesitating on hearing help, and leave a quick review so others can find it too.Connect with the Hearing Matters Podcast TeamEmail: hearingmatterspodcast@gmail.com Instagram: @hearing_matters_podcast Facebook: Hearing Matters Podcast

Send us a textIn this episode of On The Pen: The Weekly Dose, Dave Knapp breaks down why the idea of over-the-counter GLP-1 medications isn't radical speculation, it's a pattern already in motion. Drawing on FDA signals, past regulatory precedent with Orlistat, recent pricing negotiations, softened safety language, and public comments from pharmaceutical executives, Dave lays out the case that low-dose oral GLP-1s could be the first step toward OTC access. This episode connects the dots between regulation, access, pricing, and normalization of obesity treatment, and explains why the people laughing today may be asking how they missed it tomorrow.

Hoy arrancamos con el indulto de Wanda Vázquez y repasamos porque es la política con más suerte en la historia de la humanidad. Luego, más detalles del exejecutivo del del Banco Popular que aparente y alegadamente le robó $15M al banco.Entramos luego en lo último de la Reforma Contributiva: los que se mueven, los que se quedan fuera, y una Cámara que no trabajará la semana que viene mientras los numeritos siguen dando vueltas.Y sí, continúa el excelente ambiente laboral en el PNP. Si alguien pensó que enero iba a traer calma, se equivocó.En el chit-chat hablamos de los precios de las fiestas y del fin de la tregua entre Nydia Velázquez y Mamdani, porque la política no descansa ni en Nueva York ni en Puerto Rico.

For the first part of the episode description we usually say something funny, like Luke's salt and pepper beard. But this is an episode that we are so excited to release. While the Wyoming boys were on their western expedition, Luke was sitting on a few tags himself. And it wasn't until the boys tagged out that he starting looking for a deer himself. And not just a road forky, but a mule deer that makes you stop in your tracks and say "Damn, now THAT is a mule deer". And to add to the Mule deer success, less than 48 hours earlier, the boys quite literally stumbled into a herd of elk. A quick trip back into town for an OTC tag and a well executed 850 yard shot made for a long night. This is for sure a series of stories that you do not want to miss.